Zobrazeno 1 - 10
of 16
pro vyhledávání: '"R L, Carithers"'
Autor:
J. Rakela, S. Flamm, R. H. Wiesner, S. Rouillard, S. H B Han, H. Bodenheimer, A. O. Shakil, William M. Lee, R. L. Carithers, Kris V. Kowdley, E. R. Schiff, Timothy M. McCashland, Cary Caldwell, Frank V. Schiødt, J. S. Crippin, M. J. Rodriguez, M. K. Porayko, T. Davern, K. G. Benner, Rise Stribling, A. G. Tzakis, M. G. Peters, A. T. Blei, P. Martin, S. D. Lidofsky, K. A. Somberg, H. Rosen, E. Atillasoy, J. E. Hay
Publikováno v:
Liver Transplantation and Surgery. 5:29-34
Little information is available on acute liver failure (ALF) in the United States. We gathered demographic data retrospectively for a 2-year period from July 1994 to June 1996 on all cases of ALF from 13 hospitals (12 liver transplant centers). Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74ba01dcd79678e91576fc5a20833144
https://doi.org/10.1002/lt.500050102
https://doi.org/10.1002/lt.500050102
Autor:
J G, McHutchison, K, Patel, E R, Schiff, N, Gitlin, R E, Mur, G T, Everson, R L, Carithers, G L, Davis, P, Marcellin, M L, Shiffman, J, Harvey, J K, Albrecht
Publikováno v:
Alimentary pharmacologytherapeutics. 27(5)
Treatment options are limited for patients with hepatitis C virus who do not experience sustained viral eradication with pegylated interferon and ribavirin therapy.To compare, in an open-label, randomized study, long-term continuous interferon alpha-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7a42eb1e52022bbbab9da4b790b55f54
https://pubmed.ncbi.nlm.nih.gov/18081733
https://pubmed.ncbi.nlm.nih.gov/18081733
Autor:
R L, Carithers
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 6(1)
Liver transplantation has revolutionized the care of patients with end-stage liver disease. Liver transplantation is indicated for acute or chronic liver failure from any cause. Because there are no randomized controlled trials of liver transplantati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::78d56769aa157013c35f093fabe86f63
https://pubmed.ncbi.nlm.nih.gov/10648593
https://pubmed.ncbi.nlm.nih.gov/10648593
Autor:
W. S. WILKE, R. L. CARITHERS
Publikováno v:
Cleveland Clinic journal of medicine. 65(4)
Ursodiol may slow the progression of primary biliary cirrhosis, but treatment is still mainly palliative, and liver transplantation is the only definitive therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::002dc9b4b323ab57c68330eaa9899031
https://pubmed.ncbi.nlm.nih.gov/9597781
https://pubmed.ncbi.nlm.nih.gov/9597781
Autor:
R. L. Carithers
Publikováno v:
Primary Biliary Cirrhosis ISBN: 9789401060479
A variety of therapeutic agents have been proposed for treatment of patients with primary biliary cirrhosis (PBC). However, when carefully studied in controlled clinical trails, most have been found to be ineffective or too toxic for widespread use.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e4aa074bbf539ea0b6a9ebdfb4d211f
https://doi.org/10.1007/978-94-011-4884-9_18
https://doi.org/10.1007/978-94-011-4884-9_18
Autor:
R L, Carithers
Publikováno v:
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 3(5 Suppl 1)
The pathogenesis of aggressive liver injury in patients with severe disease requiring retransplantation is not well understood, although genotype and type and degree of immunosuppression and rejection episodes may be important. Nevertheless, our unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de5e35e306e2687e2b7e9858b2d5efa3
https://pubmed.ncbi.nlm.nih.gov/9377766
https://pubmed.ncbi.nlm.nih.gov/9377766
Publikováno v:
Journal of medical virology. 53(2)
Previous studies from Japan have described an association between a conserved sequence within the hepatitis C virus (HCV) genome and resistance to interferon (IFN) therapy for patients infected with HCV genotype 1b [Enomoto et al. (1995): Journal of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69b6f1e9603e29d62d2e7798ad456eb2
https://pubmed.ncbi.nlm.nih.gov/9334922
https://pubmed.ncbi.nlm.nih.gov/9334922
Publikováno v:
Advances in experimental medicine and biology. 394
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e39e3858d83f394bd02f94ae65dc5f6f
https://pubmed.ncbi.nlm.nih.gov/8815687
https://pubmed.ncbi.nlm.nih.gov/8815687
Publikováno v:
Infectious disease clinics of North America. 9(4)
Hepatitis B infection can add significantly to the morbidity and mortality of transplantation. Patients with hepatitis B can have severe recurrent disease following liver transplantation. Reactivation of occult disease can occur during chemotherapy o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e71db5015f04bd83f6a55bce495f8e9
https://pubmed.ncbi.nlm.nih.gov/8747773
https://pubmed.ncbi.nlm.nih.gov/8747773
Autor:
D R, Gretch, C E, Bacchi, L, Corey, C, dela Rosa, R R, Lesniewski, K, Kowdley, A, Gown, I, Frank, J D, Perkins, R L, Carithers
Publikováno v:
Hepatology (Baltimore, Md.). 22(1)
We report a prospective clinical and virological study of 18 patients undergoing orthotopic liver transplantation, selected because of hepatitis C virus (HCV) RNA positivity before transplantation. Nine of the 18 patients (50%) developed chronic acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c699211b82871bb01b9292af1a25a9c
https://pubmed.ncbi.nlm.nih.gov/7543438
https://pubmed.ncbi.nlm.nih.gov/7543438